Skip to main content
. 1998 Feb;111(2):402–407. doi: 10.1046/j.1365-2249.1998.00491.x

Fig. 3.

Fig. 3

Anti-HMG1/HMG2 antibody titres in individual patients between active and inactive phases. (a) Anti-HMG1 antibody. (b) Anti-HMG2 antibody. Fifteen of the 17 sera positive for anti-HMG1 antibody and 13 of the 14 sera positive for anti-HMG2 antibody showed lower titres in the inactive phase. P values by Wilcoxon signed rank test.